![](/img/cover-not-exists.png)
A084 Similar Benefit in Patients Aged q 75 Years Versus < 75 Years with VMP in First-Line MM and Bortezomib in Relapsed MM
Kropff, M, Richardson, PG, Schlag, R, Khuageva, N, Dimopoulos, MA, Shpilberg, O, Schots, R, Petrucci, M, Neuwirth, R, Boral, A, Cakana, A, Liu, K, Deraedt, W, Van de Velde, H, Miguel, J SanVolume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70452-8
Date:
February, 2009
File:
PDF, 92 KB
english, 2009